APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Screening for Carrier Diseases

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genetic Screening for Carrier Diseases Industry Growth and Trends Forecast to 2032

1 January 2026123 pages

Choose your research edition.

Industry ResearchGenetic Screening for Carrier Diseases Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Screening for Carrier Diseases Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Genetic Screening for Carrier Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Screening for Carrier Diseases Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Screening for Carrier Diseases Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

According to APO Research, the global Genetic Screening for Carrier Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Genetic Screening for Carrier Diseases market include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, Myriad Genetics, Roche, Natera and OPKO Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genetic Screening for Carrier Diseases market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genetic Screening for Carrier Diseases market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetic Screening for Carrier Diseases market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetic Screening for Carrier Diseases.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Genetic Screening for Carrier Diseases market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genetic Screening for Carrier Diseases Market by Company

Thermo Fisher Scientific

Eurofins Scientific

Illumina

Invitae

MedGenome

Myriad Genetics

Roche

Natera

OPKO Health

23andMe

bioMérieux

EKF Diagnostics

Gene by Gene (myDNA)

Fulgent Genetics

NxGen MDx

Sonic Genetics

My Baby

AncestryDNA

DiaSorin

Grifols

BGI Genomics

Chigene

Jiajian Medical Testing

Genesky

Berry Genomics

Weihansi Biomedical Technology

Annaroad

Genetic Screening for Carrier Diseases Segment by Type

NGS

Whole Exome Sequencing

Others

Genetic Screening for Carrier Diseases Segment by Application

Couple

Individual

Genetic Screening for Carrier Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Screening for Carrier Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Screening for Carrier Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Screening for Carrier Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Genetic Screening for Carrier Diseases companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Genetic Screening for Carrier Diseases Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Genetic Screening for Carrier Diseases Market Share by Region (2021-2026) Table 4. Global Genetic Screening for Carrier Diseases Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Genetic Screening for Carrier Diseases Market Share by Region (2027-2032) Table 6. Global Genetic Screening for Carrier Diseases Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2026) Table 9. Global Genetic Screening for Carrier Diseases Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Genetic Screening for Carrier Diseases Market Size Share Forecasted by Type (2027-2032) Table 11. North America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Genetic Screening for Carrier Diseases Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2026) Table 24. Global Genetic Screening for Carrier Diseases Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Genetic Screening for Carrier Diseases Market Size Share Forecasted by Application (2027-2032) Table 26. North America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Genetic Screening for Carrier Diseases Industry Trends Table 37. Genetic Screening for Carrier Diseases Industry Drivers Table 38. Genetic Screening for Carrier Diseases Industry Opportunities and Challenges Table 39. Genetic Screening for Carrier Diseases Industry Restraints Table 40. Global Genetic Screening for Carrier Diseases Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Genetic Screening for Carrier Diseases Revenue Market Share by Company (2021-2026) Table 42. Global Genetic Screening for Carrier Diseases Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Genetic Screening for Carrier Diseases Key Company Headquarters & Area Served Table 44. Global Genetic Screening for Carrier Diseases Company, Product Type & Application Table 45. Global Genetic Screening for Carrier Diseases Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Eurofins Scientific Company Information Table 54. Eurofins Scientific Business Overview Table 55. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 57. Eurofins Scientific Recent Development Table 58. Illumina Company Information Table 59. Illumina Business Overview Table 60. Illumina Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Illumina Genetic Screening for Carrier Diseases Product Portfolio Table 62. Illumina Recent Development Table 63. Invitae Company Information Table 64. Invitae Business Overview Table 65. Invitae Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Invitae Genetic Screening for Carrier Diseases Product Portfolio Table 67. Invitae Recent Development Table 68. MedGenome Company Information Table 69. MedGenome Business Overview Table 70. MedGenome Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. MedGenome Genetic Screening for Carrier Diseases Product Portfolio Table 72. MedGenome Recent Development Table 73. Myriad Genetics Company Information Table 74. Myriad Genetics Business Overview Table 75. Myriad Genetics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 77. Myriad Genetics Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Roche Genetic Screening for Carrier Diseases Product Portfolio Table 82. Roche Recent Development Table 83. Natera Company Information Table 84. Natera Business Overview Table 85. Natera Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Natera Genetic Screening for Carrier Diseases Product Portfolio Table 87. Natera Recent Development Table 88. OPKO Health Company Information Table 89. OPKO Health Business Overview Table 90. OPKO Health Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. OPKO Health Genetic Screening for Carrier Diseases Product Portfolio Table 92. OPKO Health Recent Development Table 93. 23andMe Company Information Table 94. 23andMe Business Overview Table 95. 23andMe Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. 23andMe Genetic Screening for Carrier Diseases Product Portfolio Table 97. 23andMe Recent Development Table 98. bioMérieux Company Information Table 99. bioMérieux Business Overview Table 100. bioMérieux Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. bioMérieux Genetic Screening for Carrier Diseases Product Portfolio Table 102. bioMérieux Recent Development Table 103. EKF Diagnostics Company Information Table 104. EKF Diagnostics Business Overview Table 105. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio Table 107. EKF Diagnostics Recent Development Table 108. Gene by Gene (myDNA) Company Information Table 109. Gene by Gene (myDNA) Business Overview Table 110. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio Table 112. Gene by Gene (myDNA) Recent Development Table 113. Fulgent Genetics Company Information Table 114. Fulgent Genetics Business Overview Table 115. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 117. Fulgent Genetics Recent Development Table 118. NxGen MDx Company Information Table 119. NxGen MDx Business Overview Table 120. NxGen MDx Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio Table 122. NxGen MDx Recent Development Table 123. Sonic Genetics Company Information Table 124. Sonic Genetics Business Overview Table 125. Sonic Genetics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 127. Sonic Genetics Recent Development Table 128. My Baby Company Information Table 129. My Baby Business Overview Table 130. My Baby Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. My Baby Genetic Screening for Carrier Diseases Product Portfolio Table 132. My Baby Recent Development Table 133. AncestryDNA Company Information Table 134. AncestryDNA Business Overview Table 135. AncestryDNA Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio Table 137. AncestryDNA Recent Development Table 138. DiaSorin Company Information Table 139. DiaSorin Business Overview Table 140. DiaSorin Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. DiaSorin Genetic Screening for Carrier Diseases Product Portfolio Table 142. DiaSorin Recent Development Table 143. Grifols Company Information Table 144. Grifols Business Overview Table 145. Grifols Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Grifols Genetic Screening for Carrier Diseases Product Portfolio Table 147. Grifols Recent Development Table 148. BGI Genomics Company Information Table 149. BGI Genomics Business Overview Table 150. BGI Genomics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 152. BGI Genomics Recent Development Table 153. Chigene Company Information Table 154. Chigene Business Overview Table 155. Chigene Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Chigene Genetic Screening for Carrier Diseases Product Portfolio Table 157. Chigene Recent Development Table 158. Jiajian Medical Testing Company Information Table 159. Jiajian Medical Testing Business Overview Table 160. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio Table 162. Jiajian Medical Testing Recent Development Table 163. Genesky Company Information Table 164. Genesky Business Overview Table 165. Genesky Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Genesky Genetic Screening for Carrier Diseases Product Portfolio Table 167. Genesky Recent Development Table 168. Berry Genomics Company Information Table 169. Berry Genomics Business Overview Table 170. Berry Genomics Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 172. Berry Genomics Recent Development Table 173. Weihansi Biomedical Technology Company Information Table 174. Weihansi Biomedical Technology Business Overview Table 175. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio Table 177. Weihansi Biomedical Technology Recent Development Table 178. Annaroad Company Information Table 179. Annaroad Business Overview Table 180. Annaroad Genetic Screening for Carrier Diseases Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Annaroad Genetic Screening for Carrier Diseases Product Portfolio Table 182. Annaroad Recent Development Table 183. North America Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 185. North America Genetic Screening for Carrier Diseases Market Share by Country (2021-2026) Table 186. North America Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. North America Genetic Screening for Carrier Diseases Market Share Forecast by Country (2027-2032) Table 188. Europe Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 190. Europe Genetic Screening for Carrier Diseases Market Share by Country (2021-2026) Table 191. Europe Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Europe Genetic Screening for Carrier Diseases Market Share Forecast by Country (2027-2032) Table 193. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 195. Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Country (2021-2026) Table 196. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Asia-Pacific Genetic Screening for Carrier Diseases Market Share Forecast by Country (2027-2032) Table 198. Latin America Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Genetic Screening for Carrier Diseases Market Share by Country (2021-2026) Table 201. Latin America Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Genetic Screening for Carrier Diseases Market Share Forecast by Country (2027-2032) Table 203. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Country (2021-2026) Table 206. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East & Africa Genetic Screening for Carrier Diseases Market Share Forecast by Country (2027-2032) Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Genetic Screening for Carrier Diseases Product Image Figure 3. Global Genetic Screening for Carrier Diseases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 5. Global Genetic Screening for Carrier Diseases Market Share by Region: 2025 VS 2032 Figure 6. Global Genetic Screening for Carrier Diseases Market Share by Region (2021-2032) Figure 7. North America Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. NGS Image Figure 13. Global NGS Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Whole Exome Sequencing Image Figure 15. Global Whole Exome Sequencing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Genetic Screening for Carrier Diseases Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Genetic Screening for Carrier Diseases Market Share by Type 2025 VS 2032 Figure 20. North America Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032) Figure 21. Europe Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032) Figure 23. Latin America Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032) Figure 25. Couple Image Figure 26. Global Couple Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Individual Image Figure 28. Global Individual Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Genetic Screening for Carrier Diseases Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Genetic Screening for Carrier Diseases Market Share by Application 2025 VS 2032 Figure 31. North America Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032) Figure 32. Europe Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032) Figure 34. Latin America Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Genetic Screening for Carrier Diseases Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Genetic Screening for Carrier Diseases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Genetic Screening for Carrier Diseases Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 41. Europe Genetic Screening for Carrier Diseases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Genetic Screening for Carrier Diseases Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 44. Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 47. Latin America Genetic Screening for Carrier Diseases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Genetic Screening for Carrier Diseases Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 50. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • NGS
  • Whole Exome Sequencing
  • Others
Applications
  • Couple
  • Individual
Companies covered
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Invitae
  • MedGenome
  • Myriad Genetics
  • Roche
  • Natera
  • OPKO Health
  • 23andMe
  • bioMérieux
  • EKF Diagnostics
  • Gene by Gene (myDNA)
  • Fulgent Genetics
  • NxGen MDx
  • Sonic Genetics
  • My Baby
  • AncestryDNA
  • DiaSorin
  • Grifols
  • BGI Genomics
  • Chigene
  • Jiajian Medical Testing
  • Genesky
  • Berry Genomics
  • Weihansi Biomedical Technology
  • Annaroad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Genetic Screening for Carrier Diseases Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2032)
  5. 1.4.1 Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
  6. 1.4.2 Global Genetic Screening for Carrier Diseases Market Size by Region (2027-2032)
  7. 1.5 Key Regions Genetic Screening for Carrier Diseases Market Size (2021-2032)
  8. 1.5.1 North America Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032)
2 Genetic Screening for Carrier Diseases Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 NGS
  3. 2.1.2 Whole Exome Sequencing
  4. 2.1.3 Others
  5. 2.2 Global Genetic Screening for Carrier Diseases Market Size by Type
  6. 2.2.1 Global Genetic Screening for Carrier Diseases Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Genetic Screening for Carrier Diseases Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Genetic Screening for Carrier Diseases Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Genetic Screening for Carrier Diseases Market Size by Regions
  10. 2.3.1 North America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Type (2021-2026)
3 Genetic Screening for Carrier Diseases Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Couple
  3. 3.1.2 Individual
  4. 3.2 Global Genetic Screening for Carrier Diseases Market Size by Application
  5. 3.2.1 Global Genetic Screening for Carrier Diseases Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Genetic Screening for Carrier Diseases Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Genetic Screening for Carrier Diseases Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Genetic Screening for Carrier Diseases Market Size by Regions
  9. 3.3.1 North America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Genetic Screening for Carrier Diseases Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Genetic Screening for Carrier Diseases Industry Trends
  2. 4.2 Genetic Screening for Carrier Diseases Industry Drivers
  3. 4.3 Genetic Screening for Carrier Diseases Industry Opportunities and Challenges
  4. 4.4 Genetic Screening for Carrier Diseases Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Genetic Screening for Carrier Diseases Revenue (2021-2026)
  2. 5.2 Global Genetic Screening for Carrier Diseases Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Genetic Screening for Carrier Diseases Key Company Headquarters & Area Served
  4. 5.4 Global Genetic Screening for Carrier Diseases Company, Product Type & Application
  5. 5.5 Global Genetic Screening for Carrier Diseases Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Genetic Screening for Carrier Diseases Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Genetic Screening for Carrier Diseases Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Genetic Screening for Carrier Diseases Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Eurofins Scientific
  8. 6.2.1 Eurofins Scientific Company Information
  9. 6.2.2 Eurofins Scientific Business Overview
  10. 6.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio
  12. 6.2.5 Eurofins Scientific Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Illumina Genetic Screening for Carrier Diseases Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Invitae
  20. 6.4.1 Invitae Company Information
  21. 6.4.2 Invitae Business Overview
  22. 6.4.3 Invitae Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Invitae Genetic Screening for Carrier Diseases Product Portfolio
  24. 6.4.5 Invitae Recent Developments
  25. 6.5 MedGenome
  26. 6.5.1 MedGenome Company Information
  27. 6.5.2 MedGenome Business Overview
  28. 6.5.3 MedGenome Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 MedGenome Genetic Screening for Carrier Diseases Product Portfolio
  30. 6.5.5 MedGenome Recent Developments
  31. 6.6 Myriad Genetics
  32. 6.6.1 Myriad Genetics Company Information
  33. 6.6.2 Myriad Genetics Business Overview
  34. 6.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio
  36. 6.6.5 Myriad Genetics Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Roche Genetic Screening for Carrier Diseases Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Natera
  44. 6.8.1 Natera Company Information
  45. 6.8.2 Natera Business Overview
  46. 6.8.3 Natera Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Natera Genetic Screening for Carrier Diseases Product Portfolio
  48. 6.8.5 Natera Recent Developments
  49. 6.9 OPKO Health
  50. 6.9.1 OPKO Health Company Information
  51. 6.9.2 OPKO Health Business Overview
  52. 6.9.3 OPKO Health Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 OPKO Health Genetic Screening for Carrier Diseases Product Portfolio
  54. 6.9.5 OPKO Health Recent Developments
  55. 6.10 23andMe
  56. 6.10.1 23andMe Company Information
  57. 6.10.2 23andMe Business Overview
  58. 6.10.3 23andMe Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 23andMe Genetic Screening for Carrier Diseases Product Portfolio
  60. 6.10.5 23andMe Recent Developments
  61. 6.11 bioMérieux
  62. 6.11.1 bioMérieux Company Information
  63. 6.11.2 bioMérieux Business Overview
  64. 6.11.3 bioMérieux Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 bioMérieux Genetic Screening for Carrier Diseases Product Portfolio
  66. 6.11.5 bioMérieux Recent Developments
  67. 6.12 EKF Diagnostics
  68. 6.12.1 EKF Diagnostics Company Information
  69. 6.12.2 EKF Diagnostics Business Overview
  70. 6.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio
  72. 6.12.5 EKF Diagnostics Recent Developments
  73. 6.13 Gene by Gene (myDNA)
  74. 6.13.1 Gene by Gene (myDNA) Company Information
  75. 6.13.2 Gene by Gene (myDNA) Business Overview
  76. 6.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio
  78. 6.13.5 Gene by Gene (myDNA) Recent Developments
  79. 6.14 Fulgent Genetics
  80. 6.14.1 Fulgent Genetics Company Information
  81. 6.14.2 Fulgent Genetics Business Overview
  82. 6.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio
  84. 6.14.5 Fulgent Genetics Recent Developments
  85. 6.15 NxGen MDx
  86. 6.15.1 NxGen MDx Company Information
  87. 6.15.2 NxGen MDx Business Overview
  88. 6.15.3 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio
  90. 6.15.5 NxGen MDx Recent Developments
  91. 6.16 Sonic Genetics
  92. 6.16.1 Sonic Genetics Company Information
  93. 6.16.2 Sonic Genetics Business Overview
  94. 6.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio
  96. 6.16.5 Sonic Genetics Recent Developments
  97. 6.17 My Baby
  98. 6.17.1 My Baby Company Information
  99. 6.17.2 My Baby Business Overview
  100. 6.17.3 My Baby Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 My Baby Genetic Screening for Carrier Diseases Product Portfolio
  102. 6.17.5 My Baby Recent Developments
  103. 6.18 AncestryDNA
  104. 6.18.1 AncestryDNA Company Information
  105. 6.18.2 AncestryDNA Business Overview
  106. 6.18.3 AncestryDNA Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio
  108. 6.18.5 AncestryDNA Recent Developments
  109. 6.19 DiaSorin
  110. 6.19.1 DiaSorin Company Information
  111. 6.19.2 DiaSorin Business Overview
  112. 6.19.3 DiaSorin Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 DiaSorin Genetic Screening for Carrier Diseases Product Portfolio
  114. 6.19.5 DiaSorin Recent Developments
  115. 6.20 Grifols
  116. 6.20.1 Grifols Company Information
  117. 6.20.2 Grifols Business Overview
  118. 6.20.3 Grifols Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Grifols Genetic Screening for Carrier Diseases Product Portfolio
  120. 6.20.5 Grifols Recent Developments
  121. 6.21 BGI Genomics
  122. 6.21.1 BGI Genomics Company Information
  123. 6.21.2 BGI Genomics Business Overview
  124. 6.21.3 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio
  126. 6.21.5 BGI Genomics Recent Developments
  127. 6.22 Chigene
  128. 6.22.1 Chigene Company Information
  129. 6.22.2 Chigene Business Overview
  130. 6.22.3 Chigene Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Chigene Genetic Screening for Carrier Diseases Product Portfolio
  132. 6.22.5 Chigene Recent Developments
  133. 6.23 Jiajian Medical Testing
  134. 6.23.1 Jiajian Medical Testing Company Information
  135. 6.23.2 Jiajian Medical Testing Business Overview
  136. 6.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio
  138. 6.23.5 Jiajian Medical Testing Recent Developments
  139. 6.24 Genesky
  140. 6.24.1 Genesky Company Information
  141. 6.24.2 Genesky Business Overview
  142. 6.24.3 Genesky Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Genesky Genetic Screening for Carrier Diseases Product Portfolio
  144. 6.24.5 Genesky Recent Developments
  145. 6.25 Berry Genomics
  146. 6.25.1 Berry Genomics Company Information
  147. 6.25.2 Berry Genomics Business Overview
  148. 6.25.3 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio
  150. 6.25.5 Berry Genomics Recent Developments
  151. 6.26 Weihansi Biomedical Technology
  152. 6.26.1 Weihansi Biomedical Technology Company Information
  153. 6.26.2 Weihansi Biomedical Technology Business Overview
  154. 6.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio
  156. 6.26.5 Weihansi Biomedical Technology Recent Developments
  157. 6.27 Annaroad
  158. 6.27.1 Annaroad Company Information
  159. 6.27.2 Annaroad Business Overview
  160. 6.27.3 Annaroad Genetic Screening for Carrier Diseases Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Annaroad Genetic Screening for Carrier Diseases Product Portfolio
  162. 6.27.5 Annaroad Recent Developments
7 North America
  1. 7.1 North America Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  3. 7.3 North America Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  3. 8.3 Europe Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  3. 10.3 South America Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst